Defective death receptor signaling as a cause of tumor immune escape

被引:78
作者
French, LE
Tschopp, J
机构
[1] Univ Hosp Geneva, Dept Dermatol, CH-1211 Geneva, Switzerland
[2] Univ Lausanne, Inst Biochem, CH-1066 Epalinges, Switzerland
关键词
death-receptors; fas; FLIP; apoptosis; cytolysis;
D O I
10.1006/scbi.2001.0405
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Death receptors are a subgroup of TAT-receptor family members that can trigger caspase-8 activation and apoptosis upon interaction with their selective ligands. One of the death receptors, Fas (CD95) and its ligand is critically involved in the regulation of immune homeostasis and effector function. Fas-mediated cell death is a major pathway of cytolytic T-cell-mediated death that is involved in specific killing of tumor cells. Recent investigations summarized herein have shown that defective Fas-signaling due to receptor down regulation or dysfunction, or intracellular inhibition by FLIP (FLICE inhibitory protein) can interfere with Fas-mediated tumor cell death, and thereby favor tumor immune escape.
引用
收藏
页码:51 / 55
页数:5
相关论文
共 35 条
  • [1] Gene transfer of Fas ligand induces tumor regression in vivo
    Arai, H
    Gordon, D
    Nabel, EG
    Nabel, GJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (25) : 13862 - 13867
  • [2] Apoptosis control by death and decoy receptors
    Ashkenazi, A
    Dixit, VM
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1999, 11 (02) : 255 - 260
  • [3] Death receptors: Signaling and modulation
    Ashkenazi, A
    Dixit, VM
    [J]. SCIENCE, 1998, 281 (5381) : 1305 - 1308
  • [4] RAS MUTATIONS IN HUMAN-MELANOMA - A MARKER OF MALIGNANT PROGRESSION
    BALL, NJ
    YOHN, JJ
    MORELLI, JG
    NORRIS, DA
    GOLITZ, LE
    HOEFFLER, JP
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 102 (03) : 285 - 290
  • [5] Chappell DB, 1999, CANCER RES, V59, P59
  • [6] Regulation of the proinflammatory effects of Fas ligand (CD95L)
    Chen, JJ
    Sun, YN
    Nabel, GJ
    [J]. SCIENCE, 1998, 282 (5394) : 1714 - 1717
  • [7] Essential role for oncogenic Ras in tumour maintenance
    Chin, L
    Tam, A
    Pomerantz, J
    Wong, M
    Holash, J
    Bardeesy, N
    Shen, Q
    O'Hagan, R
    Pantginis, J
    Zhou, H
    Horner, JW
    Cordon-Cardo, C
    Yancopoulos, GD
    DePinho, RA
    [J]. NATURE, 1999, 400 (6743) : 468 - 472
  • [8] The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors
    Djerbi, M
    Screpanti, V
    Catrina, AI
    Bogen, B
    Biberfeld, P
    Grandien, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) : 1025 - 1031
  • [9] Antitumor effect of allogenic fibroblasts engineered to express Fas ligand (FasL)
    Drozdzik, M
    Qian, C
    Lasarte, JJ
    Bilbao, R
    Prieto, J
    [J]. GENE THERAPY, 1998, 5 (12) : 1622 - 1630
  • [10] Fenton RG, 1998, CANCER RES, V58, P3391